Julie Christie

Statistics

Publications

Citations

H-Index

Active since

2005

Affiliations

Novartis (Singapore)(Current)

East Sussex County Council

Novartis Institutes for BioMedical Research

Novartis (Switzerland)

Julie Christie is an author at Novartis (Singapore) specializing in pharmacology, pharmacokinetic optimization, and optimization of pharmacokinetic properties.

Publications per year

2005–2015

Publications

Solubility-Driven Optimization of Phosphodiesterase-4 Inhibitors Leading to a Clinical Candidate

Neil J. Press, Roger Taylor, Joseph D. Fullerton et al. · Journal of Medicinal Chemistry · 2012 · 33 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

A new orally bioavailable dual adenosine A2B/A3 receptor antagonist with therapeutic potential

Neil J. Press, Neil J. Press, Roger Taylor et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 31 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +5

Discovery and Optimization of 4-(8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl)transcyclohexanecarboxylic Acid, an Improved PDE4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)

Neil J. Press, Roger Taylor, Joseph D. Fullerton et al. · Journal of Medicinal Chemistry · 2015 · 19 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

1–3 of 3